Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
858 studies found for:    "Hepatitis B"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Lamivudine and Adefovir to Treat Chronic Hepatitis B
Conditions: HBV (Hepatitis B Virus);   Hepatitis B;   Hepatitis
Interventions: Drug: Lamivudine and adefovir;   Drug: Adefovir alone
2 Completed Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
Conditions: Liver Diseases;   Hepatitis, Chronic;   Hepatitis, Viral, Human;   Hepatitis;   Virus Diseases;   Digestive System Diseases;   Hepatitis B, Chronic;   Hepatitis B;   DNA Virus Infections
Intervention:
3 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
4 Completed
Has Results
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
Conditions: Hepatitis B;   Chronic Hepatitis B
Interventions: Drug: Entecavir;   Drug: Telbivudine
5 Completed
Has Results
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis
Conditions: Hepatitis B, Chronic;   Cirrhosis;   Fibrosis;   Chronic Hepatitis B
Intervention: Drug: adefovir dipivoxil
6 Completed
Has Results
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
Conditions: Hepatitis B, Chronic;   Chronic Hepatitis B
Intervention: Drug: adefovir dipivoxil 10mg
7 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
8 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
9 Completed
Has Results
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
Conditions: Hepatitis B;   Hepatitis B Vaccine
Intervention: Biological: Engerix™-B
10 Enrolling by invitation Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
Conditions: Hepatitis B;   Hepatitis B, Chronic;   End Stage Liver Disease;   Carcinoma, Hepatocellular
Intervention:
11 Completed Long-Term Lamivudine Therapy for Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Procedure: Blood Testing;   Procedure: Percutaneous Liver Biopsy;   Procedure: Lamivudine Therapy
12 Terminated Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
Condition: Hepatitis B
Interventions: Drug: Lamivudine;   Biological: Recombinant hepatitis B surface antigen
13 Recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
14 Completed Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: pradefovir mesylate;   Drug: adefovir dipivoxyl
15 Completed A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Conditions: Hepatitis B;   HBV
Interventions: Drug: Single Ascending Dose (SAD) Cohorts GS-9620;   Drug: Multiple Ascending Dose (MAD) Cohorts
16 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Intervention:
17 Completed A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Interventions: Drug: Single Ascending Dose (SAD) Cohorts GS-9620;   Drug: Multiple Ascending Dose (MAD) Cohorts GS-9620
18 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
19 Unknown  Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load
Condition: Chronic Hepatitis B
Intervention: Drug: Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
20 Completed Lamivudine for Chronic Hepatitis B
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D;   Glomerulonephritis;   Polyarteritis Nodosa
Intervention: Drug: Lamivudine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years